funder logo

DAVOS ALZHEIMER'S COLLABORATIVE INC

DAVOS ALZHEIMER'S COLLABORATIVE INC

Wayne, PA, US
•
501(c)3
•
EIN
86-1884515
•
WWW.DAVOSALZHEIMERSCOLLABORATIVE.ORG
funder logo

DAVOS ALZHEIMER'S COLLABORATIVE INC

Wayne, PA, US
•
501(c)3
•
EIN
86-1884515
•
WWW.DAVOSALZHEIMERSCOLLABORATIVE.ORG
Overview
Programs
990s
Income Statement
Balance Sheet
How to Apply
Sign up for more:
People
Board & Team
Financials
Financial Trends
Funding
Funders
Grants Received
Grantmaking
Giving Insights
Grantees
Grants Given
Overlap
Hide details

Programs

  • Healthcare System Preparedness for Alzheimer's
    HEALTHCARE SYSTEM PREPAREDNESS - DAC IS INVESTING TO TRANSFORM THE WAY HEALTHCARE SYSTEMS WORLDWIDE DETECT, DIAGNOSE AND TREAT ALZHEIMER'S. THE GOAL IS TO TAKE ADVANTAGE OF FUTURE INNOVATIONS TO IMPROVE THE QUALITY OF LIFE FOR PEOPLE EVERYWHERE. IN 2022, DAC CONTINUED TO ADVANCE 7 FLAGSHIP PROJECTS IN 6 COUNTRIES AS WELL AS SUPPORT AND MONITOR THE EXECUTION OF THE INITIAL GRANTS PROGRAM (12 GRANTS IN TOTAL).
    Geographies
    Not indicated
    Dates
    Jan 1, 2022 – Dec 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $6M
  • Global Cohorts for Alzheimer's Research
    GLOBAL COHORTS - DAC IS BUILDING GLOBAL COHORTS TO ADVANCE UNDERSTANDING OF ALZHEIMER'S AMONG DIVERSE POPULATIONS. THIS DATA WILL PROVIDE THE FOUNDATION FOR IDENTIFYING NEW BIOMARKERS AND DEVELOPING TARGETED TREATMENTS THAT WORK FOR PEOPLE WORLDWIDE. IN 2022, DAC RECRUITED 23 COHORTS AROUND THE GLOBE. AS A BASIS TO BEGIN CONTRACTING, DAC ALSO EXECUTED A MEMORANDUM OF UNDERSTANDING (MOU) WITH A COHORT MANAGED BY AGA KHAN UNIVERSITY IN NAIROBI, KENYA. OUTREACH TO COHORTS WERE TARGETED THAT HAVE THE STRONGEST ALIGNMENT WITH THE SCIENTIFIC PLAN AND ACCESS TO THE TARGETED MEASUREMENTS. ALSO IN 2022, DAC PROVIDED A LETTER OF INTENT TO THE NATIONAL INSTITUTES ON HEALTH OUTLINING A 5-YEAR, $50M USD GRANT THAT WAS POSITIVELY REVIEWED.
    Geographies
    Not indicated
    Dates
    Jan 1, 2022 – Dec 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $840.9K
  • Global Clinical Trials Network
    GLOBAL CLINICAL TRIALS - DAC IS BUILDING A GLOBAL NETWORK OF CLINICAL TRIAL SITES AND A SUPPORTING TECHNOLOGY PLATFORM TO REDUCE THE COST AND TIME OF BRINGING NEW TREATMENTS TO MARKET. DAC DEVELOPED A NETWORK OF MORE THAN 30 EUROPEAN SITES ORGANIZED FOR ACCELERATING STUDIES AND IMPLEMENTING NOVEL TRIAL DESIGNS AND SECURED A PHARMACEUTICAL COMPANY SPONSOR.
    Geographies
    Not indicated
    Dates
    Jan 1, 2022 – Dec 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $661.9K
Programs
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)
Terms of Use
Privacy Policy